New MRI scan for brain metastases detection
Part of Brain & nervous system, Cancer clinical trials.
This study tests a new MRI sequence to see if it can better detect brain metastases. You may be eligible if you are scheduled for a brain MRI with contrast and have known or suspected brain metastases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are scheduled for a brain MRI with gadolinium contrast
- You have known or suspected brain metastases
- You can provide informed consent and lie still for the MRI
- You do not have any MRI contraindications or gadolinium allergy
- You do not have severe kidney problems (eGFR below 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.
This trial uses regular MRI scans to screen for brain metastases in people with certain advanced cancers (HER2-positive or triple-negative breast cancer, non-small cell lung cancer, or melanoma). The goal is to detect brain spread early, which may help guide treatment and improve outcomes.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This trial studies an MRI technique using a contrast dye (gadopetate/gadolinium) to better look at liver lesions that may be colon cancer spread. It may help doctors more accurately assess which liver tumors are present and guide next steps.
This trial tests whether doing scheduled brain MRI scans can lower the chance that lung cancer later causes symptomatic brain metastases (tumors that cause symptoms in the brain). If you’re eligible, you’ll get brain MRI surveillance at a specific time after starting radiation.
This trial tests whether two special MRI contrast medicines—gadolinium and ferumoxytol—can better diagnose problems in the brain or central nervous system. It may help doctors identify what’s causing symptoms or abnormal brain findings.
Hear when a new Brain Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.